When restricting the analysis to RA patients, we found suspected cases being less treated with abatacept or IL-6 inhibitors, although this difference did not reach statistical significance.
← all excerpts
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
1
—
—